Linical Co (TSE:2183) OCF Margin %: -14.20% (As of Mar. 2026)

What is Linical Co OCF Margin %?

Linical Co TSE:2183 -0.99% 48 OCF Margin % is -14.20% as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 48/100 and a GF Value™ of 円310.47 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Linical Co ranks better than 59.12% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Linical Co's Cash Flow from Operations for the six months ended in Mar. 2026 was 円-541 Mil. Linical Co's Revenue for the six months ended in Mar. 2026 was 円3,806 Mil. Therefore, Linical Co's OCF Margin % for the quarter that ended in Mar. 2026 was -14.20%.

As of today, Linical Co's current OCF Yield % is -35.32%.

The historical rank and industry rank for Linical Co's OCF Margin % or its related term are showing as below:

TSE:2183' s OCF Margin % Range Over the Past 10 Years
Min: -18.6 Med: 9.78 Max: 27.43
Current: -18.6

During the past 13 years, the highest OCF Margin % of Linical Co was 27.43%. The lowest was -18.60%. And the median was 9.78%.

TSE:2183's OCF Margin % is ranked better than
59.12% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs TSE:2183: -18.60

Linical Co OCF Margin % Related Terms

Linical Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Linical Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co OCF Margin % Chart

Linical Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

OCF Margin %

Get a 7-Day Free Trial

14.12

14.70

8.66

5.71

-18.60

Linical Co Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
OCF Margin %	Get a 7-Day Free Trial															6.96	9.97	1.08	-22.03	-14.20

TSE:2183 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Linical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Linical Co OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Linical Co's OCF Margin % falls into.

Save Embed

48GF Score

Linical Co Ltd TSE:2183

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Linical Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Linical Co's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Mar. 2026 )	/	Revenue (A: Mar. 2026 )
	=	-1611.422	/	8665.822
	=	-18.60 %

Linical Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-540.636	/	3806.13
	=	-14.20 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -14.20% mean?

Linical Co (TSE:2183) has a OCF Margin % of -14.20% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Linical Co and its competitors. According to the industry distribution chart, Linical Co ranks #392 out of 959 companies in the Biotechnology industry, placing it in the top 40.9%.

Is Linical Co's OCF Margin % too high?

Linical Co's current OCF Margin % is -14.20%. Based on the distribution chart, Linical Co ranks #392 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Linical Co has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Linical Co's OCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Linical Co ranks #392 out of 959 companies for OCF Margin %. This puts Linical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Linical Co and its competitors. Linical Co's current OCF Margin % is -14.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Linical Co stock overvalued right now?

Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円310.47, compared to a current price of 円200.00 — trading 35.6% below its estimated fair value. The current OCF Margin % is -14.20%. Linical Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Linical Co (TSE:2183), the current OCF Margin % is -14.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円200.00 is trading 35.6% below its estimated GF Value™ of 円310.47. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

OCF Margin %: -14.20%
GF Value™: 円310.47 vs. price of 円200.00 (35.6% below fair value)
GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:177A TSE:206A TSE:4576 TSE:2342 TSE:4893 TSE:4891 TSE:4583 TSE:4591 TSE:2385 TSE:7096 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003

Website http://www.linical.co.jp

Linical Co Ltd is a pharmaceutical company.

48GF Score

Get the complete analysis for TSE:2183

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円200.00

Price

円310.47

GF Value

View TSE:2183 Analysis

See OCF Margin % data for all stocks →